Back to HomeBeta

ICD-10 Coding for Adenocarcinoma Lung Cancer(C34.11, C78.01)

Complete ICD-10-CM coding and documentation guide for Adenocarcinoma Lung Cancer. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Lung AdenocarcinomaPulmonary Adenocarcinoma

Related ICD-10 Code Ranges

Complete code families applicable to Adenocarcinoma Lung Cancer

C34.0-C34.9Primary Range

Malignant neoplasm of bronchus and lung

This range includes codes for primary malignant neoplasms of the lung, including adenocarcinoma.

Secondary malignant neoplasm of lung

These codes are used for metastatic involvement of the lung from another primary site.

Secondary malignant neoplasm of brain

This code is used for brain metastasis originating from a primary lung adenocarcinoma.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C34.11Malignant neoplasm of upper lobe, right bronchus or lungUse when adenocarcinoma is confirmed in the right upper lobe of the lung.
  • Histological confirmation of adenocarcinoma
  • Imaging showing mass in right upper lobe
C78.01Secondary malignant neoplasm of right lungUse when adenocarcinoma has metastasized to the right lung.
  • Evidence of metastasis to the right lung from another primary site

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for adenocarcinoma lung cancer

Essential facts and insights about Adenocarcinoma Lung Cancer

The ICD-10 code for adenocarcinoma of the lung is C34.11 for the right upper lobe.

Primary ICD-10-CM Codes for adenocarcinoma lung cancer

Malignant neoplasm of upper lobe, right bronchus or lung
Billable Code

Decision Criteria

clinical Criteria

  • Confirmed adenocarcinoma in the right upper lobe

Applicable To

  • Adenocarcinoma of right upper lobe

Excludes

  • Benign neoplasms of lung

Clinical Validation Requirements

  • Histological confirmation of adenocarcinoma
  • Imaging showing mass in right upper lobe

Code-Specific Risks

  • Misclassification if histology is not confirmed

Coding Notes

  • Ensure histological confirmation is documented before using this code.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Personal history of other malignant neoplasm of bronchus and lung

Z85.118
Use for patients with a history of lung cancer.

Encounter for follow-up examination after completed treatment for malignant neoplasm

Z08
Use for follow-up visits post-treatment.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Malignant neoplasm of unspecified part of bronchus or lung

C34.9
Use C34.9 only when the specific location within the lung is not documented.

Malignant neoplasm of upper lobe, right bronchus or lung

C34.11
Differentiate based on whether the neoplasm is primary or secondary.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Adenocarcinoma Lung Cancer to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C34.11.

Impact

Clinical: Impacts treatment decisions and surgical planning., Regulatory: Non-compliance with coding guidelines., Financial: Potential for reduced reimbursement.

Mitigation Strategy

Ensure imaging and pathology reports specify the affected lobe., Train staff on the importance of detailed documentation.

Impact

Reimbursement: May lead to lower reimbursement due to lack of specificity., Compliance: Non-compliance with coding standards., Data Quality: Decreases accuracy of cancer registry data.

Mitigation Strategy

Ensure histological confirmation is attempted and documented.

Impact

Risk of audit if histological confirmation is not documented.

Mitigation Strategy

Ensure all diagnoses are supported by pathology reports.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Adenocarcinoma Lung Cancer, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Adenocarcinoma Lung Cancer

Use these documentation templates to ensure complete and accurate documentation for Adenocarcinoma Lung Cancer. These templates include all required elements for proper coding and billing.

Initial Diagnosis of Adenocarcinoma

Specialty: Oncology

Required Elements

  • Histological type
  • Tumor location
  • Metastatic status
  • Biomarker results

Example Documentation

Patient presents with a 3 cm mass in the right upper lobe. Biopsy confirms adenocarcinoma, TTF-1 positive, EGFR mutation negative.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Lung cancer diagnosed.
Good Documentation Example
Adenocarcinoma of the right upper lobe confirmed by biopsy, TTF-1 positive.
Explanation
The good example provides specific histological and locational details necessary for accurate coding.

Need help with ICD-10 coding for Adenocarcinoma Lung Cancer? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more